From the Guidelines
The eye abnormality most commonly associated with ataxia and difficulties with swallowing and drinking is dysmetric saccades. Dysmetric saccades are inaccurate eye movements where the eyes overshoot or undershoot the intended target, requiring corrective movements. This occurs because the cerebellum, which is affected in conditions causing ataxia, plays a crucial role in coordinating precise eye movements. The same cerebellar dysfunction that causes the ataxia (uncoordinated movements) also affects the accuracy of saccadic eye movements. Cerebellar pathology disrupts the fine-tuning of motor commands that control both limb movements and eye movements. While upbeating nystagmus can occur with certain cerebellar lesions, particularly those affecting the anterior vermis, dysmetric saccades are more consistently observed in patients with cerebellar ataxia and would be the more characteristic finding in this clinical presentation 1.
Some key points to consider in the evaluation of ataxia include:
- The clinical evaluation by history and careful neurological examination will provide the localization information necessary to guide the choice of imaging 1
- Truncal ataxia and titubation (rhythmic and spasmodic nodding or swaying of the head or body) are seen especially, although not exclusively, with disorders that involve the midline cerebellum 1
- If the underlying pathology involves the cord, there may be weakness, hyperreflexia, spasticity, and sensory loss in addition to ataxia 1
- MRI of the entire brain without and with IV contrast is the preferred modality for initial assessment for a mass, any process that may result in edema and enhancement, and neurodegenerative disorders 1
In terms of the specific eye abnormalities associated with ataxia, it is worth noting that:
- Dysmetric saccades are a common finding in patients with cerebellar ataxia 1
- Upbeating nystagmus can occur with certain cerebellar lesions, particularly those affecting the anterior vermis 1
- Other eye abnormalities, such as ocular dysmetria, can also be seen in patients with ataxia 1
Overall, the evaluation of ataxia requires a careful and comprehensive approach, taking into account the patient's clinical presentation, neurological examination, and imaging findings. Dysmetric saccades are a key eye abnormality to look for in patients with ataxia, particularly those with cerebellar dysfunction 1.
From the Research
Eye Abnormalities in Ataxia
The patient's presentation of ataxia, dysphatia (difficulty in drinking), and dyspharia (difficulty in swallowing) can be associated with various eye abnormalities.
- Upbeating nystagmus or dysmetric saccades are common oculomotor abnormalities found in patients with spinocerebellar ataxias (SCAs) 2.
- Studies have shown that oculomotor abnormalities are present in 94.8% of SCA patients, including those in early stages of the disease, and correlate with disease severity 2.
- Other eye movement abnormalities, such as saccadic intrusions, nystagmus, and hypo/hypermetric saccades, are also common in SCA patients 2.
- Ataxia telangiectasia, a type of ataxia, is characterized by striking abnormalities of saccadic generation, including hypometric saccades, increased saccadic latency, and absence of smooth pursuit and optokinetic nystagmus 3.
- Friedreich ataxia, another type of ataxia, is associated with vestibular, saccadic, and fixation abnormalities, including prolonged saccadic latency, square wave jerks, and ocular flutter 4.
Oculomotor Abnormalities in Ataxia
Oculomotor assessment is essential in evaluating patients with ataxia, as it can provide important information for differential diagnosis 5.
- Nystagmus is a common finding in ataxia, but other oculomotor abnormalities, such as oculomotor apraxia, supranuclear gaze palsy, and impaired fixation, can also be present 5.
- The type and severity of oculomotor abnormalities can vary depending on the specific type of ataxia and the stage of the disease 2, 4.
- Oculomotor abnormalities can be used as clinical biomarkers in natural history studies and clinical trials of ataxia 2, 4.